Literature DB >> 28388418

Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.

Katherine B Chiappinelli, Pamela L Strissel, Alexis Desrichard, Huili Li, Christine Henke, Benjamin Akman, Alexander Hein, Neal S Rote, Leslie M Cope, Alexandra Snyder, Vladimir Makarov, Sadna Budhu, Dennis J Slamon, Jedd D Wolchok, Drew M Pardoll, Matthias W Beckmann, Cynthia A Zahnow, Taha Merghoub, Timothy A Chan, Stephen B Baylin, Reiner Strick.   

Abstract

Year:  2017        PMID： 28388418     DOI： 10.1016/j.cell.2017.03.036

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  38 in total

Review 1.  Immune checkpoint-based therapy in myeloid malignancies: a promise yet to be fulfilled.

Authors:  Jan Philipp Bewersdorf; Maximilian Stahl; Amer M Zeidan
Journal:  Expert Rev Anticancer Ther       Date:  2019-03-19       Impact factor: 4.512

Review 2.  Hypomethylating agents for treatment and prevention of relapse after allogeneic blood stem cell transplantation.

Authors:  Thomas Schroeder; Christina Rautenberg; Rainer Haas; Ulrich Germing; Guido Kobbe
Journal:  Int J Hematol       Date:  2017-11-15       Impact factor: 2.490

3.  Recent evolution of a TET-controlled and DPPA3/STELLA-driven pathway of passive DNA demethylation in mammals.

Authors:  Christopher B Mulholland; Atsuya Nishiyama; Joel Ryan; Ryohei Nakamura; Merve Yiğit; Ivo M Glück; Carina Trummer; Weihua Qin; Michael D Bartoschek; Franziska R Traube; Edris Parsa; Enes Ugur; Miha Modic; Aishwarya Acharya; Paul Stolz; Christoph Ziegenhain; Michael Wierer; Wolfgang Enard; Thomas Carell; Don C Lamb; Hiroyuki Takeda; Makoto Nakanishi; Sebastian Bultmann; Heinrich Leonhardt
Journal:  Nat Commun       Date:  2020-11-24       Impact factor: 14.919

4.  DNMT1 in Six2 Progenitor Cells Is Essential for Transposable Element Silencing and Kidney Development.

Authors:  Szu-Yuan Li; Jihwan Park; Yuting Guan; Kiwung Chung; Rojesh Shrestha; Matthew B Palmer; Katalin Susztak
Journal:  J Am Soc Nephrol       Date:  2019-03-08       Impact factor: 10.121

5.  PD-L1 methylation regulates PD-L1 expression and is associated with melanoma survival.

Authors:  Goran Micevic; Durga Thakral; Meaghan McGeary; Marcus W Bosenberg
Journal:  Pigment Cell Melanoma Res       Date:  2018-11-22       Impact factor: 4.693

6.  Methylation of immune synapse genes modulates tumor immunogenicity.

Authors:  Anders Berglund; Matthew Mills; Ryan M Putney; Imène Hamaidi; James Mulé; Sungjune Kim
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

7.  Demethylation and epigenetic modification with 5-azacytidine reduces IDH1 mutant glioma growth in combination with temozolomide.

Authors:  Alex Shimura Yamashita; Marina da Costa Rosa; Alexandra Borodovsky; William T Festuccia; Timothy Chan; Gregory J Riggins
Journal:  Neuro Oncol       Date:  2019-02-14       Impact factor: 12.300

Review 8.  Immune escape and immunotherapy of acute myeloid leukemia.

Authors:  Luca Vago; Ivana Gojo
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

9.  Fra-2/AP-1 regulates melanoma cell metastasis by downregulating Fam212b.

Authors:  Guang-Liang Chen; Rui Li; Xiao-Xiang Chen; Juan Wang; Shan Cao; Rui Song; Ming-Chun Zhao; Li-Ming Li; Nicole Hannemmann; Georg Schett; Cheng Qian; Aline Bozec
Journal:  Cell Death Differ       Date:  2020-11-13       Impact factor: 15.828

10.  Zebularine elevates STING expression and enhances cGAMP cancer immunotherapy in mice.

Authors:  Junzhong Lai; Yajuan Fu; Shuoran Tian; Shanlu Huang; Xuan Luo; Lili Lin; Xing Zhang; Hanze Wang; Zhang Lin; Heng Zhao; Shujin Lin; Junhong Zhao; Shan Xu; Daliang Li; Shaoli Cai; Luna Dong; Jing Qian; Jiadi Liang; Qiumei Li; Yong Zhang; Jiqiang Fan; Robert Balderas; Qi Chen
Journal:  Mol Ther       Date:  2021-02-09       Impact factor: 11.454
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.